Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy

Current Allergy and Asthma Reports

Volumn 7, Issue 4, 2007, Pages 274-279

  Mehndiratta, Man Mohan ^a   Singh, Avinash Chandra ^b  

^a G B PANT HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; IRON; PREDNISONE; STEROID;

ANEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE DURATION; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ELECTRODIAGNOSIS; EVIDENCE BASED MEDICINE; FATIGUE; HEALTH CARE ACCESS; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LIMB WEAKNESS; MAINTENANCE THERAPY; MORTALITY; NERVE BIOPSY; OUTCOME ASSESSMENT; PARESTHESIA; PHYSICAL DISABILITY; PLASMAPHERESIS; POLYRADICULONEUROPATHY; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

HUMANS; MOTOR NEURONS; NEURONS, AFFERENT; PLASMAPHERESIS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 34250759708     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0041-z     Document Type: Review

References (40)

1. Köller H, Kieseier BC, Jander S, Hartung HP: Medical progress Chronic inflammatory demyelinating polyneuropathy N Engl J Med 2005, 352:1343-1356.
2. Austin JH: Recurrent polyneuropathies and their corticosteroid treatment; with five year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 1958, 81:157-192.
3. Thomas PK, Lascelles RG, Hallpike JF, Hewer RL: Recurrent and chronic relapsing Guillain-Barre polyneuritis. Brain 1969, 92:589-606.
4. Dyck PJ, Lais AC, Ohta M, et al.: Chronic inflammatory polyradiculo-neuropathy. Mayo Clinic Proc 1975, 50:621-637.
5. Prineas JW, McLeod JG: Chronic relapsing polyneuritis. J Neurol Sci 1976, 27:427-458.
6. Bouchard C, Lacrocoix C, Plante V, et al.: Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999, 52:498-503.
7. Bosch PE, Smith BE: Disease of peripheral nerves. In Neurology in Clinical Practice. Edited by Bradley WG, Daroff RB, Fenichel GM, Marsden ED. London: Butterworth-Heinemann; 2004:2299-2401.
8. Hughes R: Chronic inflammatory demyelinating polyradiculineuropathy. Pract Neurol 2002, 2:198-207.
9. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:617-618.
10. Saperstein DS, Katz JS, Amato AA, Barohn RJ: Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24:311-324.
11. Hughes R, Bensa S, Willison H, et al. for the Inflammatory Neuropathy Cause and Treatment (INCAT) Group: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195-201.
12. Latov N: Diagnosis of CIDP. Neurology 2002, 59 (Suppl 6):52-56.
13. Hahn AF: Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. Revue Neurologique (Paris) 1996, 152:328-332
14. Van Doorn PA, Brand A, Vermeulen M: Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 1987, 37:1798-1802.
15. Yan WX, Archelos JJ, Hartung HP, et al.: P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:286-292.
16. Dyck PJ, Daube J, O'Brien P, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986, 314:461-465.
17. Dyck PJ, Pineda A, Swanson C, et al.: The Mayo Clinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP). Prog Clin Biol Res 1982, 106:197-204.
18. Hahn AF, Bolton CF, Pillay N, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. A double blind, sham-controlled, crossover study. Brain 1996, 119(Pt 4):1055-1066.
19. Mehndiratta MM, Hughes RAC, Agarwal P: Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2004, 3: CD003906.pub2. DOI:10.1002/ 14651858.
20. Hahn AF, Bolton CF, Zochodne D, Feasby TE: Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo controlled, cross-over study. Brain 1996, 119:1067-1077.
21. Mendell JR, Barohn RJ, Freimer ML, et al.: Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56:445-449.
22. Dalakas MC: Mechanisms of action of Mg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002, 59(Suppl 6):S13-S21.
23. Van Schaik IN, Winer JB, De Haan R, Vermeulen M: Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002, 2:CD001797.
24. Sghirlanzoni A, Solari A, Ciano C, et al.: Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 2000, 21:31-37.
25. Mehndiratta MM, Hughes RA: Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002, 1:CD002062.
26. Ropper AH: Current treatments for CIDP. Neurology 2003, 60(Suppl 3):S16-S22.
27. Vermeulen M, van Doorn PA, Brand A, et al.: Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993, 56:36-39.
28. Khatri BO, McQuillen MP, Harrington GJ, et al.: Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 1985, 35:312-319.
29. Tsokos GC, Balow JE: Immunosuppressive agents and plasmapheresis in immunological disorders. J Immunopharmacol 1985, 7:1-15.
30. Heininger K, Liebert UG, Toyka KV, et al.: Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G. J Neurol Sci 1984, 66:1-14.
31. Pollard JD, McLeod JG, Gatenby P, et al.: Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation. J Neurol Sci 1983, 58:269-287.
32. De Luca G, Lugaresi A, Iarlori C, et al.: Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1999, 95:190-194.
33. Levy RL, Newkirk R, Ochoa J: Treating chronic relapsing Guillain-Barré syndrome by plasma exchange. Lancet 1979, 2:259-260.
34. Server AC, Lefkowith J, Braine H, et al.: Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurol 1979, 6:258-261.
35. Bromberg MB, Feldman EL, Jaradeh S, Albers JW: Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Epidemiol 1992, 45:47-52.
36. Dyck PJ, O'Brien PC, Oviatt KF, et al.: Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982, 11:136-141.
37. Pollard JD: A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies. Muscle Nerve 1987, 10:214-221.
38. Gorson KC, Allam G, Ropper AH: Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997, 48:321-328.
39. Dyck PJ, Litchy WJ, Kratz KM, et al.: A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36:838-845.
40. Hughes RAC, Swan AV, van Doorn PA: Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review). Cochrane Database Syst Rev 2004, 4:10.1002/ 14651858. CD003280.pub2.